Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer

NCT05524584 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Metastatic Breast Cancer
Hormone Receptor-positive Breast Cancer
HER2-negative Breast Cancer

Interventions

DRUG: Fulvestrant
DRUG: Anastrozole
DRUG: Abemaciclib

Sponsor

University of California, Irvine